Professor Jayne Hope obtained a degree in Biological Sciences from the University of Birmingham, UK in 1991, and a PhD degree from the University of Manchester, UK in 1994. She then carried out postdoctoral research at Kings College, London, UK and subsequently at the Institute for Animal Health, Compton, UK.

Professor Hope joined The Roslin Institute, University of Edinburgh, UK in 2011 and was awarded a personal chair in immunology in 2017. Her research group studies cellular immune responses in cattle with a particular focus on understanding the role of innate cells in driving natural and vaccine-induced immunity to mycobacterial diseases including bovine tuberculosis and Johne’s disease. She also leads the Immunological Toolbox at The Roslin Institute.

James is Professor of Pharmaceutical Sciences and Deputy Head of the School of Pharmacy and Pharmaceutical Sciences, Cardiff University. Professor Birchall graduated from Bath University in 1993 and completed his PhD researching drug and DNA delivery systems in 1998 (Cardiff University). Current research includes microneedle delivery of contraceptives, therapeutics, immunotherapeutics and vaccines into the skin and pulmonary drug delivery.

James has acted as Associate Editor of Critical Reviews in Therapeutic Drug Carrier Systems, a member of the Editorial Board of Expert Review of Medical Devices, a temporary advisor to the WHO and an expert advisor to the British Pharmacopoeia and conducted research funded by the EU, PATH, Bill & Melinda Gates Foundation, NIH, Wellcome Trust, EPSRC, MRC, Welsh Government, Royal Society, Innovate UK and various charities and pharmaceutical companies.

Campbell is Chief Scientific Officer (CSO) and Cambridge Site Head at Abzena and has a PhD in Immunology from the University of Manchester, an Executive MBA from Judge Business School, Cambridge University and has published a number of papers on cell-mediated immunity, immunotherapy and vaccines.

Campbell has over 25 years of experience working in the biotech and diagnostics sector. Throughout his career he has applied innovative solutions for the design, manufacture and clinical evaluation of novel products including vaccines, biologics, and small molecules in multiple therapeutic areas. These include inflammation, cancer, infectious disease, and addiction.